KLHL3 and Hyperkalemia: [10] reported a variant of the KLHL3 gene that resulted in a p.arg431trp missense mutation in a 58‐year‐old Turkish woman, in whom persistent hyperkalemia had been noted 9 years earlier, after discontinuation of a valsartan plus HTZ (12.5 mL) regimen.